Akkermansia
Akkermansia muciniphila
TL;DR
Akkermansia muciniphila is a next-generation probiotic. One small human RCT of the pasteurized form showed modest metabolic benefits; evidence is early but mechanistically interesting.
Ideal For
- Insulin-resistant or overweight adults already doing the basics
- People interested in gut-barrier support with an experimental mindset
Avoid If
- You are immunocompromised
- You want established, well-replicated evidence
- The product does not specify the pasteurized strain
Frequently Asked Questions
Overview
Akkermansia muciniphila lives in the mucus layer of the gut and typically makes up 1-4% of the adult microbiome. Lower abundance is consistently observed in obesity, type 2 diabetes and inflammatory bowel disease, which is what put it on the map as a therapeutic candidate.
The pivotal human data is a 2019 exploratory, randomized, double-blind, placebo-controlled trial in 32 insulin-resistant, overweight adults (Depommier et al., Nature Medicine). Three months of daily pasteurized A. muciniphila improved insulin sensitivity, modestly reduced insulinemia and total cholesterol, and produced a small drop in body weight versus placebo. Curiously, the pasteurized form outperformed the live form, likely because the surface protein Amuc_1100 survives pasteurization and drives TLR2 signalling.
That is one small trial. Product quality varies enormously, and most consumer capsules are not the pasteurized strain used in the research. Treat this as promising, not established.
How It Works
- Degrades and stimulates turnover of intestinal mucin, thickening the protective mucus layer
- Surface protein Amuc_1100 signals through TLR2 to tighten epithelial junctions
- Raises endocannabinoid-related lipids that regulate gut barrier and inflammation
- Cross-feeds short-chain-fatty-acid producers via mucin-derived sugars
Health Concerns Addressed
No linked health concerns yet.
Supporting Research7 studies
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
Depommier C, Everard A, Druart C +13 more
Pasteurized Akkermansia muciniphila for 3 months was safe and improved insulin sensitivity by roughly 30% with small reductions in weight, fat mass and cholesterol.
Akkermansia muciniphila supplementation in patients with overweight/obese type 2 diabetes: Efficacy depends on its baseline levels in the gut
Zhang Y, Liu R, Chen Y +5 more
In participants with low baseline A. muciniphila, AKK-WST01 supplementation showed high colonization efficiency and significant reductions in body weight, fat mass, and HbA1c, which were not found in the placebo group.
Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels
Suenaert P, Segers A, Rymenans L +4 more
The primary endpoint of whole-body insulin sensitivity (Matsuda index) did not differ after 4-months of daily administration of capsules containing 30 billion cells of pasteurized A. muciniphila MucT compared to placebo in the intention-to-treat subjects.
Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation
Perraudeau F, McMurdie P, Bullard J +14 more
A multi-strain formulation containing Akkermansia muciniphila lowered post-meal glucose AUC and HbA1c by about 0.6 points in metformin-treated type 2 diabetes.
Pasteurized Akkermansia muciniphila HB05 (HB05P) Improves Muscle Strength and Function: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Kang CH, Jung ES, Jung SJ +6 more
The HB05P group showed significant improvements in peak torque and peak torque per body weight of the left leg extensor muscles compared to the placebo group.
Comparing the effects of yogurt containing Akkermansia muciniphila postbiotic with yogurt containing Lactobacillus rhamnosus postbiotic on body composition, biochemical indices, appetite, and depression scores in overweight or obese adults
Aalipanah E, Askarpour M, Eskandari MH +5 more
In the AMY group, significant reductions were observed in waist circumference, waist-to-height ratio, body fat percentage, aspartate aminotransferase levels, and appetite scores compared with the control group.
Serum metabolite profiling yields insights into health promoting effect of A. muciniphila in human volunteers with a metabolic syndrome
Depommier C, Everard A, Druart C +7 more
Common responses encompassed modulation of amino acid metabolism, characterized by reduced levels of arginine and alanine, alongside several intermediates of tyrosine, phenylalanine, tryptophan, and glutathione metabolism.
Safety Information
Potential Side Effects
Generally well tolerated in the trial; occasional mild bloating or altered stool consistency in the first weeks.
Contraindications
Avoid in severe immunosuppression, central venous catheters or critical illness, as with any live or bacterial-derived product. People with inflammatory bowel disease should discuss with a clinician first.
Drug Interactions
- No known drug interactions; theoretical caution with immunosuppressants
Pregnancy & Breastfeeding
Pregnancy: insufficient_data
Breastfeeding: insufficient_data
Dosage Guidelines
Dosage Used in Studies
Consult healthcare provider
Best Time to Take
With any meal, once daily
Best Form
Pasteurized strain matching the trial material
Dosing by Goal
| Goal | Dose | Notes |
|---|---|---|
| 10 billion CFU-equivalent/day | Dose used in the 3-month human trial |
Forms Compared
The form used in the human RCT; heat-treated, non-viable
Oxygen-sensitive anaerobe; viability claims hard to verify
Food & Timing
Taken with a meal in the trial; no evidence timing matters much.
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.